Please login to the form below

Not currently logged in
Email:
Password:

heart disease

This page shows the latest heart disease news and features for those working in and with pharma, biotech and healthcare.

Lilly trumpets Trulicity heart data in face-off with Novo Nordisk

Lilly trumpets Trulicity heart data in face-off with Novo Nordisk

cardiovascular disease, says Lilly, as less than a third (31%) of patients had established heart disease at enrolment. ... The company has discussed a larger outcomes trial for Ozempic, but seems to have taken a different tack for now, testing the drug

Latest news

More from news
Approximately 6 fully matching, plus 308 partially matching documents found.

Latest Intelligence

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Its pivotal APOLLO trial showed nearly all patisiran-treated patients saw the disease halted or slowed, with more than half seeing their neuropathy reversed. ... disease which is seen as key for patients’long term survival, and is already under review

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    Heart disease and cancer mortality rates have risen in recent years as more urban ‘westernised’lifestyles take hold, along with major public health issues such as air pollution. ... AstraZeneca’s goal is to realise complete disease management,

  • Made in China Made in China

    of heart disease, diabetes and cancer. ... Nevertheless, China’s demographics, growing wealth and growing burden of disease means it will be an increasingly key market in the coming decades, and an increasingly active player in pharma’s

  • Waking the sleeping giant Waking the sleeping giant

    While it is true that less than 50% of Africans enjoy access to modern healthcare facilities at present, and that Africa suffers from one-quarter of the world’s disease burden, ... In addition, SMS and voice messaging are being used for patient

  • Tackling the challenge of non-adherence Tackling the challenge of non-adherence

    Improving patient adherence… is one way of improving this efficiency as there is decreased spending on hospitalisations, re-admissions, disease progression and complications.”. ... 80% in just five disease areas - asthma, type 2 diabetes, coronary

More from intelligence
Approximately 0 fully matching, plus 24 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics